| Glycobiology | Pages |
Newly found 2-N-acetyl-2,6-dideoxy-[beta]-glucopyranose containing methyl glucose polysaccharides in M.bovis BCG: revised structure of the mycobacterial methyl glucose lipopolysaccharides
Introduction
Results
Discussion
Materials and methods
Acknowledgments
Abbreviations
References
Newly found 2-N-acetyl-2,6-dideoxy-[beta]-glucopyranose containing methyl glucose polysaccharides in M.bovis BCG: revised structure of the mycobacterial methyl glucose lipopolysaccharides
The specific mycobacterial methyl polysaccharides 3-O-methyl mannose polysaccharide (MMP) and the 6-O-methyl glucose lipopolysaccharides (MGLPs) were shown to modulate the fatty acid biosynthesis by the mycobacterial fatty acid synthetase I (FAS I). This activity is attributed to their fatty acid complexing properties allowing the release of the neosynthesized fatty acyl chain from the enzyme and probably their transport in the cell. To elucidate, at a molecular level, the mechanism of this unusual kind of polysaccharide-lipid biological interaction, we first analyzed, by mass spectrometry and proton nuclear magnetic resonance (1H NMR) spectroscopy, the structure of the polysaccharidic backbone (MGPs) of the MGLPs from Mycobacterium bovis BCG. This work reveals that this strain produces a new kind of MGP containing an unusual monosaccharide never described in the mycobacterial genus: a 2-N-acetyl-2,6-dideoxy-[beta]-glucopyranosyl. In addition, 1H NMR data afforded evidence for the revision of three glycosidic linkages described previously. These modifications affect mainly the reducing end tetrasaccharide and have great consequences on the previously proposed molecular model of the MGP.
Key words: mycobacterium/methyl glucose lipopolysaccharides/2-N-acetyl-[beta]-quinovosamine/NMR
Introduction
Among infectious diseases, tuberculosis remains the leading cause of mortality with an estimated 2.9 million deaths and 8 million new cases each year (Murray et al., 1993). Moreover, during the past decade, its incidence has dramatically increased in the developed countries, renewing interest in this almost-forgotten disease (Bloom and Murray, 1992). This reversal of the tuberculosis situation is mainly attributed to the appearance of multi-drug-resistant strains of M.tuberculosis as a consequence of carelessness infection control policies (Weiss, 1992; Nowak, 1995). Thus, the challenge today for combating the outbreak of tuberculosis relies on the development of new antituberculous agents. The efforts made in this way are mainly addressed toward the search for biosynthesis inhibitors of the major components of the mycobacterial cell wall since this structure is thought to act as a protective barrier (Jarlier and Nikaido, 1994; Nikaido, 1994). The specific peptidoglycan-arabinogalactan-mycoloyl complex, which is the covalently linked backbone of the mycobacterial cell wall, represents a potential target for the development of new drugs. However, its biosynthesis is still poorly understood and real efforts are necessary in this field. Recently, though, two major advances were achieved with (1) the development of a d-arabinosyl transferase assay (Lee et al., 1995) allowing the study of biosynthesis of the d-arabinan portion of the arabinogalactan domain of the cell wall, and (2) the finding of the molecular basis of the Isoniazid (INH) (most widely used antituberculous drug) resistance (Dessen et al., 1995). This latest work shows that INH target was a 2-trans-enoyl reductase (encoded by the mycobacterial inhA gene) involved in the mycolic acid biosynthesis and more precisely in the elongation of the mero mycolic chain from a fatty acyl precursor: the enoyl-ACP. Further kinetic study indicates that the optimum chain length precursor is the hexadecenoyl-CoA (C16-CoA) derivative (Quemard et al., 1995). The origin of those precursors is still not known, although one can expect that the fatty acyl chain is synthesized in the cytoplasm by the mycobacterial FAS I complex described by Bloch (Vance et al., 1973; Bloch, 1975). The activity of this multienzymatic complex (Odriozola et al., 1977) as well as the length of the released neosynthesized fatty acyl CoA derivative (Peterson and Bloch, 1977) were shown to be modulated by specific mycobacterial methyl polysaccharides (Ilton et al., 1971; Gray and Ballou, 1975; Banis et al., 1977). These polysaccharides-the 3-O-methyl mannose polysaccharide (MMP) (Gray and Ballou, 1971) and the 6-O-methyl glucose lipopolysaccharides (MGLP) (Lee and Ballou, 1964)-raise the rate of overall synthesis and shift the neosynthesized chain length pattern from the long to the short one, increasing the latter's proportion (mainly hexadecanoate) from 25% to 85% (Flick and Bloch, 1974). These effects are thought to result from their ability to complex acyl CoA (the higher affinity being for the C16-CoA; Machida and Bloch, 1973), thus facilitating the release of the neosynthesized chain from the enzyme. Moreover, due to their complexing properties, these methyl polysaccharides were also proposed to act as lipid carrier in the cell (Bloch, 1977). These properties suggest that these molecules could play a key role in the synthesis of the fatty acyl precursor of the mycobacterial cell wall mycolic acids (Goren, 1972). Thus, in order to confirm this role and to further understand the molecular basis of this unique specific recognition between fatty acid and polysaccharide, we undertook a reinvestigation of the 6-O-methyl glucose lipopolysaccharides (MGLP). The structure of the MGLP from Mycobacterium smegmatis has been the focus of extensive work from Ballou's group (Saier and Ballou, 1968a-c; Forsberg et al., 1982; Dell and Ballou, 1983). However, recently, our reinvestigation of the MGLP from a slow growing pathogenic mycobacteria, i.e., M.xenopi, led us to show that the polysaccharidic core (MGP) presents a great heterogeneity of length, methylation degree, and side chain glucosyl substitution (Tuffal et al., 1995a,b). Since the functional properties of these molecules may be affected by such heterogeneity, we analyzed the MGLPs from the vaccinating M.bovis BCG (strain Pasteur), to confirm that this finding is not specific of M.xenopi but a general feature from mycobacterial MGLPs.
Here we report the purification and the structural elucidation of MGPs from M.bovis BCG by mass spectrometry and 2D 1H NMR spectroscopy. We identify a new molecule containing a 2-N-acetyl-2,6-dideoxy-[beta]-Glcp described for the first time in the mycobacterial genus, and we propose to revise the general structure of the mycobacterial MGLPs polysaccharide backbone.
Results
MGPs characterization
The MGLPs from M.bovis BCG were purified as previously described by affinity chromatography on an octadecyl silica bound gel and deacylated by mild alkali treatment to lead to the MGPs, analyzed by HPAEC. The chromatogram obtained (Figure
Figure 1. HPAEC analysis of the purified M.bovis BCG MGPs.Eluent A was 0.1 M NaOH and eluent B was 0.5 M CH3COONa in 0.1 M NaOH. Elution was performed at 1 ml/min and started with a step of 38% of eluent B for 2 min followed by a concave gradient from 38% to 48% of eluent B in 60 min. Shaded peaks were collected. As for others, peak A was tentatively attributed on basis of its retention time, to a short chain MGP (MGP15,10 or MGP16,11) similar to those previously described in M.xenopi (Tuffal et al., 1995b). However, coinjection with these latter in more resolutive chromatographic conditions reveals a lower retention time (Figure Table I.
Peak
A
B
C
D
E
% amount
Absolute
5
18
6
37
16
Relativea
14
49
16
100
43
Molecular ions
{RCOOH+Na}+
3562
3375
3551
3537
3523
{RCOONa+Na}+
3584
3397
3573
3559
3545
Fragment ions
C17
2963
2949
C16
2801
2787
C[prime]15
2621
2607
[le]C14
C14: 2463, C13: 2287, C12: 2111, C11: 1935, C10: 1759,
C9: 1583, C8: 1407, C7: 1231, C6: 1055.
MGP
Unknown
19,12
20,13
20,12
20,11
Figure 2. HPAEC and positive LSIMS analysis of the MGP A. Inset a: HPAEC chromatogram of the coinjected MGP A and purified M.xenopi MGP15,10 and MGP16,11 (elution was performed with 38% of eluent B in A); b, positive LSIMS spectrum of purified MGP A (masses are reported in Table I). Thus, in order to gain information on its structure, this MGP was analyzed by 1H NMR spectroscopy. However, due to the small amount of purified compound, some signals, particularly those of the glyceric acid, could not be detected and the complete structural elucidation of this new MGP has first required a complete 1H NMR analysis of the quantitatively major MGP20,12.
1H NMR study of the MGP20,12
The 1D 1H NMR spectrum (Figure
Figure 3. 500 MHz partial 1H NMR 30 ms mixing time HOHAHA spectrum of the MGP20,12 in D2O. (f2: [delta] 3.31 - 4.35 / f1: [delta] 4.92 - 5.6) showing connectivities involving anomeric protons. Cross peaks are labeled with a roman numeral identifying the residue followed by the number assigning the proton atom. Shaded background spots are observed in the 10ms mixing time HOHAHA spectrum and corresponds to the H-1-H-2 correlations. Partial attribution of those spin systems was achieved by performing several 2D HOHAHA experiments with increasing mixing time in order to assign sequentially the different resonances. In Figure With longer mixing time (100 or 175 ms) the spectrum becomes much more complex, although some additional correlation can be assigned unambiguously (Table 2). Moreover, from these latest spectra, the proton resonances of the aglycon moiety (i.e., glyceric acid) were localized, respectively, at 4.262 ppm for the H-2 and 3.952, 3.92 for the H-3, H-3[prime] (Hunter et al., 1979). Table II.
Residue
H-1
H-2
H-3
H-4
H-5
H-6
I
5.552
3.578
4.029
3.645
3.871
II
5.508
3.714
4.023
III
5.491
3.688
4.00
IV
5.477
3.889
4.28
3.832
V
5.469
3.727
3.535
VI
5.458
3.608
4.078
VII
5.452
3.708
4.02
VIII
5.449
3.716
4.012
IX
5.089
3.613
3.87
3.588
4.07
4.03/3.83
X
5.00
3.86
4.30
3.83
3.961
3.512
XI
4.971
3.361
3.575
3.48
3.838
4.021
XII
4.969
Aglycon
4.262
3.95/3.92
To establish the linkage and the ramification sites, the MGP20,12 was analyzed by 1H NMR dipolar correlation spectroscopy (ROESY experiment). From Figure Figure 4. 500 MHz partial 1H NMR ROESY spectrum of the MGP20,12 in D2O (f2: [delta] 3.31 - 4.35 / f1: [delta] 4.92 - 5.6). Shaded background cross peaks are discussed in the text. ->GlcpVI[alpha](1->4){ GlcpXI[beta](1->3)}GlcpX[alpha] (1->6)GlcpIX[alpha](1->2)Glyceric acid In a same way, proton chemical shift analysis of the different residues (Table 2) reveals a strong deshielding of proton H-2 and H-3 of unit IV, suggesting that this residue must be the second disubstituted monosaccharide. This is confirmed by the presence of the two correlation spots noted {XII1-IV3} and {I1-IV4}, indicating that the second [beta]-Glcp is linked to the C-3 while unit I substitutes the C-4 of residue IV. Finally, the weak correlation at [delta]f1 = 5.477 (IV1), [delta]f2 = 4.078 (VI3) suggests that unit IV glycosylates residue VI. However, the unambiguous determination of this latest linkage position was hindered by the complexity of the spectrum resulting from a strong overlapping. However, similar 1H NMR investigation performed in DMSO-d6 instead of D2O (unpublished observations) afforded evidence for an [alpha](1->4) linkage between those two residues and confirm the above data. Thus, from this study we can propose the following new structure for the M.bovis BCG MGP20,12 (Figure Figure 5. Proposed structure of the MGP20,12. a, Glcp in the MGP20,11; b, 6-O-Me-Glcp in the MGP20,13; c, absent from the MGP19,12. Brackets indicate tentative attribution.
Structure of the MGP A
Comparative analysis of 1H 1D NMR spectrum of the MGP A in D2O (Figure
Figure 6. 500 MHz 1H NMR spectrum of the MGP A. (a) Complete spectrum in D2O; (b) and (c) enlargement of the anomeric and aliphatic proton resonance zone; (d) spectrum obtained in H2O (20% D2O, pH 4.5) revealing the amide proton.
Figure 7. 500 MHz partial 1H NMR 100 ms mixing time HOHAHA spectrum of the MGP A in DMSO-d6 (f2: [delta] 4.62 - 5.21 / f1: [delta] 1.38 - 7.62). a, 1D spectrum; b, 2D spectrum.
Discussion
This work has extended our knowledge on the mycobacterial MGLPs in two important ways. First, the observation of a new type of methyl glucose polysaccharidic core containing an unusual carbohydrate residue: a 2-N-acetyl-2,6-dideoxy-[beta]-Glcp. This was first detected by anion exchange chromatography and mass spectrometry analysis. HPAEC shows that M.bovis BCG produce a complex mixture of MGP similar to the one previously reported for M.xenopi (excepted the lack of longer chain polysaccharides MGP21,12 and MGP21,11 observed in the two studied strains of M.xenopi; Tuffal et al., 1995a,b). Moreover, in agreement with all the mycobacterial strains analyzed, the two most abundant component of the mixture are the polysaccharides containing 20 and 19 residues (MGP20,11, MGP20,12, MGP20,13, and MGP19,11, MGP19,12). They account for only 59% and 18% ([Sigma] = 77%) of the MGP mixture, respectively, while in M.smegmatis they represent 95% (83% and 12%, respectively). Besides those, M.bovis BCG also produce some quantitatively minor MGPs with lower retention times found only in the slow growing mycobacterial strain. In the case of M.kansasii or the two studied strains of M.xenopi, these were shown to correspond to shorter MGP containing 15 or 16 Glcp residues. It is unlikely that the low retention time of MGP A results only from the presence of the 2-N-acetyl-2,6-dideoxy-[beta]-Glcp instead of a [beta]-Glcp. It is noteworthy that the change of this single monosaccharide among 20 affects the chromatographic behavior of the polysaccharide so much. However, this result is consistent with the previously observed effect of the presence of hexosamines, which are much less retained than hexoses in these chromatographic conditions.
Finally, the complete structural elucidation of MGP A has been achieved thanks to the preliminary 1H NMR analysis of the MGP20,12. Taken together, mass spectrometry and NMR spectroscopy data indicate that the MGP A differs from the quantitatively major MGP20,12 by the presence of a branched 2 NAc quinovosamine in place of Glcp residue on the reducing end trisaccharide. The role or the effect of this sugar still remains undetermined. However, it has been proposed previously that the Glcp residue found in this position can be succinylated on its primary hydroxyl group (OH-6) in the native MGLP. Thus, the presence of 6-deoxy hexose prevents such modifications and thus may have a role in the interaction between this compound and the fatty acyl ligand.
The second major finding of this work is the revision of the general structure of the polysaccharidic backbone of the mycobacterial MGLPs. 1H NMR dipolar coupling (ROESY) suggested that the reducing end closer branched Glcp residue is bound by a [beta](1->3) linkage instead of [beta](1->4) as described previously. Unfortunately, it has been shown that this kind of experiment could lead to incorrect linkage assignment since the dipolar exchange depends on proton proximity rather than on bond connectivity. Indeed, in some cases, the relative conformation of the sugar rings may results in bringing the anomeric proton closer to a proton other than the one involved in the glycosidic linkage. Such a situation may thus result in the presence of cross peaks in the spectrum, which can leads to false conclusion. Moreover, since our proposal differs from the previous structure only by a positional isomery, this could not be confirmed by more primary linkage analysis methods such as methylation analysis since the two structures will give the same results.
Nevertheless, some other evidences allow us to propose this different structural model. First of all are the chemical shifts of the two [beta]-Glcp ring protons (strictly superimposed) which are in agreement with the absence of any substitution. This first observation is inconsistent with the previous model and strongly suggests that those two residues (XI and XII) are located at nonreducing ends of the molecule and must correspond to the two ramifications. Consequently, the anomery of Glcp VI (substituting the residue X) must be [alpha] , as confirmed by the pattern of its H1-H2 cross peak observed in the HOHAHA spectrum. The second convincing point regarding the linkage position of the main chain on residue X arises from the comparative structural study of the MGP19,12. We previously determined, on the basis of FAB/MS and methylation analysis data, that this compound differs from the quantitatively major MGP20,12 by the absence of residue XI (Tuffal et al., 1995a). Moreover, the absence of the expected 2,4,6 tri-O-Me, 3-O-Ac-glucitol strongly suggested a different linkage type. This was latter confirmed by 1H NMR analysis (unpublished observations), which shows an upfield shift of the H3 proton signal of residue X confirming the absence of substitution at this position and consequently that residue VI is linked to the Xth by a 1->4 linkage.
Since we can reasonably imagine that the MGP20,12 arises from the same metabolic pathway and derives from the MGP19,12 by action of [beta]3glucosyltransferase on residue X, all these arguments tend to confirm the correctness of the ROESY spectrum interpretation and lead us to propose the following new revised structure of the mycobacterial MGP (Figure
The consequences of these structural revisions are quite important for the proposed model of interaction between these molecules and their putative ligand (acyl-CoA derivatives) since they indicate that the main polysaccharidic chain is almost exclusively constituted by [alpha](1->4) linked Glcp residues with the exception of the reducing end terminal monosaccharide. Indeed, by analogy with the amylose V type structure, it has been previously proposed that MGLP and their deacylated counterparts MGP could adopt a helical conformation generated as a consequence of the stereochemical constraints due to the [alpha](1->4) linkages (Bloch, 1977). Such conformation therefore results in the formation of a cylindrical hydrophobic cavity in which the fatty acid derivative is included. However, molecular modeling reveals that the presence of a [beta]1->3 linkage in the main chain of the previously proposed structure leads to an important break point at the reducing end side of the helix (Figure
Figure 8. Structural model of the MGP20,12. (a) Revised structure; (b) previous structure; glyceric acid and the three modified linkages are shown (boldface type corresponds to the modified main chain linkage). This precise structure determination is a necessary step for understanding the mechanism of this unique biological interaction between lipids and polysaccharide. Moreover, preliminary data, using capillary zone electrophoresis coupled to mass spectrometry, have confirmed the formation of stoichiometric complex between MGLP and their putative biological ligand: fatty acyl-coenzyme A. A more exhaustive study using different polysaccharidic or lipidic partners of various lengths will be necessary in characterizing more precisely the specificity and recognition mechanism. From a biological point of view, these molecules have been shown to have a key role in the fatty acid biosynthesis and thus indirectly on the cell wall mycoloyl-arabinogalactan backbone formation. Moreover, since they are very specific of the mycobacterial genus, search of specific inhibitors of their biosynthesis would be of great value for the development of new antituberculous drugs.
Materials and methods
Purification of MGLPs
MGLPs were purified as described previously (Hindsgaul and Ballou, 1984; Tuffal et al., 1995a) from 15 day old culture of M.bovis BCG strain Pasteur grown as pellicle on Sauton medium.
Briefly, the cells (100 g wet weight) were extracted thoroughly with a mixture of CHCl3/CH3OH (2/1). The dried crude lipidic extract (55 g) in chloroform (10 ml/g) was extensively washed with water. The different water washing fraction were pooled and the MGLPs were recovered from the aqueous phase by reverse phase-FPLC on a 60 ml column (Merck) packed with HPLC reverse phase (C18, 25-60 µm, Merck). Elution was run in steps of 200 ml of mixtures containing increasing amounts of methanol in water (0%, 20%, 40%, 70%, and 100% (v/v)) at 2.5 ml/min. Fractions from each step were pooled and analyzed by GC and GC/MS after methanolysis and trimethylsilyl (TMS) derivatization. As previously the MGLPs were eluted with 70% methanol in water and were further purified on a G50 Sephadex gel filtration column eluted with 30 mM ammonium acetate. Elution was monitored by refractive index and sulfuric anthron carbohydrate assay (OD 630 nm). Fractions containing MGLPs (20 mg) were pooled and lyophilized.
HPAEC analysis of MGPs
Prior HPAEC analysis, the MGLPs were deacylated with 0.1 M NaOH for 15 min at room temperature yielding MGPs. The mixture was neutralized with 1 M HCl, extracted with chloroform and desalted using reverse phase C18 T Sep Pak (Millipore) chromatography with step elution with water and 70% methanol in water. Salts were eluted in the water fraction and MGPs in the 70% methanol eluate.
HPAEC analysis was conducted with ~1 µg of MGPs using a DX 300 Dionex system equipped with an eluent degas module, a gradient pump and a Carbopac PA1 column (4 × 250 mm). Eluents were made using (18 M[Omega]) deionized water (Millipore), 50% dilute sodium hydroxide (Baker), and ACS grade sodium acetate (Merck). Eluent A was 0.1 M NaOH and eluent B was 0.5 M CH3COONa in 0.1 M NaOH. Elution was performed at 1 ml/min and started with a step of 38% of eluent B for 2 min followed by a concave gradient (no. 7) from 38% to 48% of eluent B for 60 min. Detection was monitored by a PED detector (Pulsed Electrochemical Detector) with a standard wave program for carbohydrate (gold electrode without pH reference, E1 = 0.1 V (0.5s), E2 = 0.6V (0.1s), E3 = -0.6V (0.05s)).
Purification of MGPs for LSIMS analysis was performed with the same system but using a semipreparative column (9 × 250 mm), eluted at 5 ml/min.
Desalting of MGPs after HPAEC purification
HPAEC fractions were neutralized using HCl (1 M) and applied to a C18 T Sep-Pak cartridge (Millipore) eluted with water and mixtures of 20 and 70% (v/v) of methanol in water. Salts were eluted in the water fraction and in the 20% methanol in water fraction. MGPs were recovered in the 70% of methanol fraction.
LSIMS analysis of MGPs
MS spectra were recorded on a two-sector instrument ZAB-SE (VG Analytical) in the positive and negative modes. The cesium beam energy was 35 kV and the accelerating voltage was 8 kV. Full spectra were recorded over a mass range of 800-4000 and a resolution of [Delta]M/M of 800. Data were processed on a Vax 2000 station (Digital). Sample (1 µl of MGPs at 5 µg /µl) was mixed with thioglycerol (10% of acetic acid) and deposited on a probe tip.
NMR analysis
MGPs were exchanged twice with D2O, dried and dissolved in D2O (100% Atom, Sigma) or DMSO-d6 (100% Atom, Sigma) at final concentration of 6 mg/ml for the MGP20,12 and less then 2 mg/ml for the MGP A. NMR spectroscopy was performed on a Brucker AMX 500 spectrometer operating at 500 MHz for 1H and equipped with a X32 computer. Spectra were recorded at 313K and chemical shifts were referenced indirectly to tetramethylsilane setting the HOD peak at 4.8 ppm.
The one-dimensional proton (1D 1H) spectrum was measured using a 90° tipping angle for the pulse and 1 s as a recycle delay between each of the 1024 acquisitions of 2 s. The spectral width of 3915 Hz was digitized on 8192 points that were multiplied by a Lorentz-Gauss function (LB = -3 Hz,GB = 0.4) prior to processing to 16384 real points in the frequency domain.
All 2D NMR data sets were recorded without sample spinning. The data were acquired in the phase-sensitive mode using the time-proportional phase increment (TPPI) method (Marion and Wüthrich, 1983), except for COSY experiments.
COSY 45 were performed according to the standard pulse sequences supplied by Bruker. A spectral width of 3508 Hz in both dimensions was used to collect a 4096 × 1024 data matrix with four transients for each t1 increment. The data matrix was multiplied by an unshifted sine-bell function in both dimensions before Fourier transformation.
The homonuclear Hartmann-Hahn (HOHAHA) spectra (Bax and Davies, 1985) was acquired with a MLEV-17 sequence, increasing mixing time from 10 to 175 ms and a spectral width of 3915 Hz. The relaxation delay was 1 s and the data matrix was 4096 × 1024 points, with 8 scans × t1 values. For processing, a sine-bell window shifted by [pi]/2 was applied in both dimensions.
ROESY spectra were acquired with the Bruker standard pulse sequence using 120 ms continuous wave spin lock time. 4096 × 1024 points, with 16 scans × t1 values were collected over a sweep width of 2000 Hz. The final data were multiplied by a [pi]/2 shifted square sine bell prior Fourier transformation (4K × 1[Kgr]).
Analytical methods
Routine gas chromatography (GC) was performed on a Girdel series 30 chromatograph equipped with an OV1 wall-coated open tubular capillary column (0.32 mm × 25 m, Spiral France) using nitrogen gas at a flow of 2.5 ml/min with a flame ionization detector set at 310°C. A temperature program from 100°C to 250°C at a speed of 3°C/min was used for trimethylsilyl methyl glycoside analysis. GC/MS experiments were done on a Hewlett Packard 5889X mass spectrometer working in electron impact (EI) and chemical ionization (CI) (NH4+) modes.
Molecular modeling
Graphics were performed on a ELAN Silicon Graphics workstation using INSIGHT and Discover program from Biosym (San Diego, CA) molecular modeling package.
The MGPs model was generated in two steps (Tuffal et al., 1995b) according to the amylose V structure (Zugenmaier and Sarko, 1976) with six residues per turn.
Acknowledgments
We thank C. Ponthus (Sanofi Recherche, Toulouse, France) for mass spectrometry analysis. This work was supported by grants from Ministère de l' Education Nationale, De l' Enseignement Superieur, de la Recherche et de l'Insertion Professionnelle ACC SV6/9506005 and from the region Midi-Pyrénées, RECH/9407528 .
Abbreviations
INH, soniazid; Enoyl-ACP, enoyl-acyl carrier protein; MGP, methyl glucose polysaccharides; MGPm,n, methyl glucose polysaccharide composed of m glucose residues n of which are mono-O-methylated; MGLP, methyl glucose lipopolysaccharides; FAS I, fatty acid synthetase, type 1; HPAEC, high pH anion exchange chromatography; LSIMS, liquid secondary-ion mass spectrometry; Glcp, d-glucopyranose.
References
1To whom correspondence should be addressed
This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: www-admin{at}oup.co.uk
Last modification: 10 Jun 1998
Copyright©Oxford University Press, 1998.
This article has been cited by other articles:
![]() |
M. Jackson and P. J. Brennan Polymethylated Polysaccharides from Mycobacterium Species Revisited J. Biol. Chem., January 23, 2009; 284(4): 1949 - 1953. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Stadthagen, T. Sambou, M. Guerin, N. Barilone, F. Boudou, J. Kordulakova, P. Charles, P. M. Alzari, A. Lemassu, M. Daffe, et al. Genetic Basis for the Biosynthesis of Methylglucose Lipopolysaccharides in Mycobacterium tuberculosis J. Biol. Chem., September 14, 2007; 282(37): 27270 - 27276. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Berg, D. Kaur, M. Jackson, and P. J Brennan The glycosyltransferases of Mycobacterium tuberculosis--roles in the synthesis of arabinogalactan, lipoarabinomannan, and other glycoconjugates Glycobiology, June 1, 2007; 17(6): 35R - 56R. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

